734 Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin.
http://stm.sciencemag.org/content/9/376/eaak9537
733 Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
http://stm.sciencemag.org/content/9/375/eaah6510
732 Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.
http://www.nature.com/nature/journal/v542/n7639/full/nature21052.html
731 Systemic Immunity Is Required for Effective Cancer Immunotherapy.
http://www.cell.com/cell/fulltext/S0092-8674(16)31738-X
730 Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors.
http://www.pnas.org/content/114/4/740.abstract
729 Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response.
http://immunology.sciencemag.org/content/2/7/eaah6413
728 Human tumors that display extensive chromosomal aberrations appear to be more resistant to immune attack.
http://science.sciencemag.org/content/355/6322/eaaf8399
727 Integrated genomic characterization of oesophageal carcinoma.
http://www.nature.com/nature/journal/v541/n7636/full/nature20805.html
726 Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.
http://www.nature.com/nm/journal/v23/n1/abs/nm.4232.html
725 Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation.
http://www.nature.com/nm/journal/v23/n1/abs/nm.4252.html
724 A genome-wide CRISPR screen reveals that FZD5, but none of the other nine Frizzled receptors encoded in the human genome, is a therapeutic vulnerability of pancreatic and colorectal tumors bearing RNF43 mutations.
http://www.nature.com/nm/journal/v23/n1/abs/nm.4219.html
723 Syrosingopine sensitizes cancer cells to killing by metformin.
http://advances.sciencemag.org/content/2/12/e1601756
722 Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response.
http://immunology.sciencemag.org/content/2/7/eaah6413
721 Prostate cancer cells escape androgen deprivation therapy by morphing into a cell type that does not require androgens.
http://science.sciencemag.org/content/355/6320/78
720 SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
http://science.sciencemag.org/content/355/6320/84
719 Molecular profiling of single circulating tumor cells from lung cancer patients.
http://www.pnas.org/content/113/52/E8379.abstract
718 Targeting metastasis-initiating cells through the fatty acid receptor CD36.
http://www.nature.com/nature/journal/vaop/ncurrent/full/nature20791.html
717 Mechanism of early dissemination and metastasis in Her2+ mammary cancer.
http://www.nature.com/nature/journal/v540/n7634/full/nature20609.html
716 NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer.
http://www.nature.com/nature/journal/v540/n7634/full/nature20597.html
715 Early dissemination seeds metastasis in breast cancer.
http://www.nature.com/nature/journal/v540/n7634/full/nature20785.html
|
